Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. - Wikidata - awgldk - TriplyDB

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

http://www.wikidata.org/entity/Q34606557

about

11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease MR-less surface-based amyloid assessment based on 11C PiB PET Chocolate, Air Pollution and Children's Neuroprotection: What Cognition Tools should be at Hand to Evaluate Interventions?Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders Testing the right target and right drug at the right stage Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected Brain PET in the diagnosis of Alzheimer's disease Development of positron emission tomography β-amyloid plaque imaging agents Ushering in the study and treatment of preclinical Alzheimer disease Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation 18F-florbetaben Aβ imaging in mild cognitive impairment Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue Three dimensions of the amyloid hypothesis: time, space and 'wingmen'Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease Contributions of academic laboratories to the discovery and development of chemical biology tools Clinical profile of PiB-positive corticobasal syndrome Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials Imago Mundi, Imago AD, Imago ADNI Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers PET amyloid-beta imaging in preclinical Alzheimer's disease Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old.Logopenic and nonfluent variants of primary progressive aphasia are differentiated by acoustic measures of speech production.Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerations Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Measuring Cortical Connectivity in Alzheimer's Disease as a Brain Neural Network Pathology: Toward Clinical Applications.Brain imaging of neurovascular dysfunction in Alzheimer's disease.Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.[Late-onset depression : Pathophysiology, diagnostics and treatment].Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project.Future Directions in Imaging Neurodegeneration.Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.

P2860

Q24194742-4F4EFB4C-8645-4B15-B918-48CB108CE324 Q24594531-C7BE5C07-EF0B-4E29-8B35-A40ED17A25A9 Q24595802-E5A1E7B2-2770-4395-972D-9B7619813B04 Q24618963-D747F722-00BA-4401-A86E-DE987DE63D15 Q26738827-6B329C84-99FD-4050-BD5C-164F74F7B1AD Q26774743-A3C7E210-D026-4C2E-9504-162A31FEEEE1 Q26830467-4C4BE83D-DC5B-4488-ACD1-3EFE2D4BD1A6 Q26850298-14392F00-6FB5-4408-8AC3-842DA0C0D8AB Q26864854-39901E41-D83C-4887-85EE-4E3720B79BE0 Q26995405-F84966F7-7B71-4C58-A5E9-8C13B1230502 Q26995432-81A3BF7C-535F-4F7F-B982-54A890693234 Q27007436-3800EF2F-123D-4A5B-A72C-EEE487A0DF5B Q27011549-19C6358F-688B-40DA-A59E-CF221BF99C6C Q27012742-B0C12D41-5BE6-4FA3-952D-9BF5D24A3403 Q27014791-7A65F236-7C72-47F2-91D4-80776CFA2608 Q27303745-3B00328C-43B2-4476-ABC0-ECCAF68D33DF Q27499311-CC8C7D3D-4464-48D6-98A6-C5B9E1494FAD Q27679935-EE9BC10F-3FFF-4AA7-9B3F-555ED1AF4DBB Q28082768-C9133665-4200-4B13-AD16-EEBBB0BE6E6F Q28087176-C1E75035-FA62-4FD4-A076-AD4D65C2E952 Q28389188-3AABBE01-AC71-4F98-9E19-62EB1322E492 Q28486042-A8419E6B-5109-4160-8AEF-EC81E50ED95D Q28488143-BDFD65A0-8E5F-41EE-93ED-895BCA6A1BE7 Q28650395-33D3C645-2AB9-4483-AB83-D5B588FCD22A Q28714253-30B84C1C-C146-4DCD-9258-E7F4632BA2BC Q29620245-E1F51A99-3C94-42A9-AA74-D075A22CE23A Q30040695-01D38848-BF43-4641-8896-F29EAE04B791 Q30303122-03534F4C-0C1B-451A-8FC7-9B6183CE914F Q30442108-0CF21D7A-F8F5-4BF4-94D4-157CB751DE4E Q30588684-48F673C0-9E23-4CE2-B467-AC5B44E331D6 Q30666527-F5AD5C09-7B9A-4CF3-A5E1-059B998B3DFA Q30764286-F37E7E47-C4CD-46A2-AD13-F430CB4111EF Q30971403-453F1764-50A5-47B4-9612-41B419B1962D Q31047403-C2FDD119-3EE8-4AAC-B4AE-F858E0A60F24 Q31066988-DC7D0DEB-DF08-48F7-BA52-105306DC0C07 Q31121286-850BFC8C-4A38-4A69-B0D9-53B3B0186CED Q31121945-195DCD12-9FD4-411F-A5E0-1E676C7BED1D Q31155701-C5D6C1BF-2B03-4C38-A06C-82E6B0104684 Q31162702-BD4D7075-7E63-4F9D-ADB5-1FD6CC032F3C Q33556068-E678742C-C764-4F75-B845-4EAABC3B93D4

P2860

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

http://www.wikidata.org/entity/Q34606557

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@ast

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@en

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@nl

type

label

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@ast

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@en

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@nl

prefLabel

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@ast

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@en

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@nl

P1433

Q34606557-A92F4182-21E0-49AE-A61D-5D35EDA84A5B

P1476

Q34606557-D00DA2A8-ADFC-4D8A-8CA4-30EE007553DA

P2093

Q34606557-0EDE2C52-D6A2-4437-8248-E5B86F65A3E3

Q34606557-2901CCC5-C738-46C9-AA3A-E53B59575581

Q34606557-4D5B3256-4B27-4ABB-AEAE-25A76D5041B8

Q34606557-C44042D6-B0AC-41CF-BDF5-39C5A48CF1C0

Q34606557-CACCE1D7-FF83-4B84-A843-F670C7A8A914

Q34606557-D7AB7785-9B48-4D87-8C30-FB958492F0C3

Q34606557-DAC01DD9-F7A0-4D4E-ADC9-E1CE5DAB4C50

Q34606557-F59BE5A4-4CB5-404E-A37B-BCD35C6D6815

P2860

Q34606557-16AB84C0-E7B6-40B6-89C4-E33D9D6AE99B

Q34606557-18965934-8B2F-4872-8CC2-7A0F4F1EDD8E

Q34606557-1C285B31-4589-47CE-B74D-F2E104B6DCF0

Q34606557-38BF934B-A3A3-4A95-B867-00E275A95D26

Q34606557-3A284B3C-AFCB-48AA-A79F-53EB0A4DB370

Q34606557-3AF7A649-56D1-41BC-BB43-BFD07263154A

Q34606557-3CCE092D-FC69-4488-9A79-A18352389086

Q34606557-48AAA968-AA4C-4074-8276-07DA0205EEFA

Q34606557-4AADF511-FFC8-4299-9BF3-F05083CAF40E

Q34606557-51568B0B-982D-436D-B91E-B9A4C6A6D5CB

P304

Q34606557-4F860637-5466-4FE5-9592-E57AB589BFCD

P31

Q34606557-171C763E-F0D5-467D-A635-A7E834A0833C

P356

Q34606557-936E3A9C-54B6-4B57-A69B-7EF721BC762F

P433

Q34606557-33F09189-F950-4284-9771-77A8E40258BF

P478

Q34606557-E96E2CD5-6218-4A97-8B14-7E2D57E00FFF

P50

Q34606557-034436CF-D0E3-4B95-A58B-8E73825554B3

Q34606557-1D76DE0B-7998-465A-B053-C2221BABE19C

Q34606557-23B4418E-286C-40E5-8D9F-2C8DCBE6585E

Q34606557-2A8E87C8-DDE4-426F-936E-FAEA16F0647F

Q34606557-43136D1A-0B61-4F8E-A94E-DA7D1D8A63BC

Q34606557-81027D54-53AF-44C1-B844-C3E8054AF548

Q34606557-D820A4EE-AF4A-4DB3-8202-3AF8A9E8E420

Q34606557-E0CD3C76-32B2-4DB8-9A85-6677437246E8

Q34606557-E271E3E6-1EC1-466F-8F37-44B0C7C4ED31

P577

Q34606557-A2919F20-05AB-4970-B983-A4B2DD2EBE7A

P5875

Q34606557-7FE1E927-1C1E-4ADA-ABF4-9142CE8D1B2B

P698

Q34606557-C27D7879-2E9F-4A96-B242-5F98A9EE4FD8

P921

Q34606557-CDF6BFB7-DEC2-4058-939F-308DA485F633

P932

Q34606557-41B9608C-AF4E-4288-9458-29F15C1C91F1

P356

P1433

Annals of Neurology

P1476

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

@en

P2093

Chester A Mathis

http://www.w3.org/2001/XMLSchema#string

Christopher C Rowe

http://www.w3.org/2001/XMLSchema#string

David Ames

http://www.w3.org/2001/XMLSchema#string

Gaël Chételat

http://www.w3.org/2001/XMLSchema#string

Graeme O'Keefe

http://www.w3.org/2001/XMLSchema#string

Rachel S Mulligan

http://www.w3.org/2001/XMLSchema#string

Uwe Ackermann

http://www.w3.org/2001/XMLSchema#string

Victor L Villemagne

http://www.w3.org/2001/XMLSchema#string

P2860

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.

Amyloid imaging in mild cognitive impairment subtypes.

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

P304

181-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.22248

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

William E. Klunk

Cassandra Szoeke

Gareth R. Jones

Pierrick Bourgeat

Olivier Salvado

Kathryn A Ellis

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49797305

http://www.w3.org/2001/XMLSchema#string

P698

21280088

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3045039

http://www.w3.org/2001/XMLSchema#string